Form S-1/A Elevation Oncology, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Elevation Oncology (ELEV) Files 6.25M Share IPO at $15-$17/sh
June 23, 2021 3:42 PM EDTElevation Oncology (NASDAQ: ELEV) has filed to IPO 6.25M shares at $15-$17 per share.
ELEV is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. It is focused on identifying... More
